The sales of Nervous System Medicines in Germany are projected to increase steadily from $7.17 billion in 2024 to $7.67 billion in 2028. In 2023, the market stood at an actual value of $7.05 billion. This represents a consistent growth trend, with year-on-year growth rates smoothing between 1.8% to 1.9%. Over a five-year horizon, from 2024 to 2028, the compound annual growth rate (CAGR) is approximately 1.7%, suggesting a stable escalation in market performance.
Looking ahead, several future trends are noteworthy:
- Advancements in neurology and biotechnology potentially driving innovation.
- Increased prevalence of neurological disorders affecting demand.
- Policy changes related to healthcare coverage in Germany.
- Impact of global economic factors and currency fluctuations.
